Detalhe da pesquisa
1.
Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study.
Ann Rheum Dis
; 78(2): 171-178, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194275
2.
Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy.
Arthritis Res Ther
; 21(1): 102, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30999933
3.
Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs.
RMD Open
; 4(1): e000662, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29765703